Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 107.00
-13.00 (-10.83%)
Aug 26, 2026, 12:17 PM CST
Bonraybio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 332.21 | 306.31 | 222.88 | 159.64 | 106.27 | 56.3 | |
Revenue Growth | 22.63% | 37.43% | 39.61% | 50.22% | 88.78% | 111.72% |
Cost of Revenue | 75.18 | 67.79 | 47.92 | 39.85 | 25.68 | 16.72 |
Gross Profit | 257.03 | 238.52 | 174.96 | 119.79 | 80.59 | 39.58 |
Selling, General & Admin | 86.94 | 83.74 | 72.24 | 57.34 | 47.72 | 34.24 |
Research & Development | 64.76 | 54.83 | 41.76 | 41.12 | 39.51 | 43.84 |
Operating Expenses | 151.7 | 138.57 | 114.01 | 98.45 | 87.23 | 78.08 |
Operating Income | 105.33 | 99.95 | 60.95 | 21.34 | -6.64 | -38.5 |
Interest Expense | -0.11 | -0.13 | -0.18 | -0.22 | -0.15 | -0.21 |
Interest & Investment Income | 7.27 | 6.88 | 3.95 | 3.01 | 1.46 | 0.58 |
Currency Exchange Gain (Loss) | 4.6 | -2.24 | 3.54 | 0.16 | 5.8 | -0.68 |
Other Non Operating Income (Expenses) | 0.2 | 0.32 | 0.12 | 0.96 | 1.25 | 7.54 |
EBT Excluding Unusual Items | 117.29 | 104.78 | 68.39 | 25.25 | 1.71 | -31.27 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.42 |
Other Unusual Items | - | - | - | 0.5 | - | - |
Pretax Income | 117.29 | 104.78 | 68.39 | 25.75 | 1.71 | -31.69 |
Income Tax Expense | 9.31 | 2.27 | 0.03 | 0.03 | 0.02 | 0.02 |
Net Income | 107.98 | 102.51 | 68.37 | 25.73 | 1.69 | -31.71 |
Net Income to Common | 107.98 | 102.51 | 68.37 | 25.73 | 1.69 | -31.71 |
Net Income Growth | 27.79% | 49.94% | 165.75% | 1423.09% | - | - |
Shares Outstanding (Basic) | 30 | 30 | 28 | 28 | 25 | 20 |
Shares Outstanding (Diluted) | 31 | 30 | 28 | 28 | 25 | 20 |
Shares Change | -6.76% | 9.08% | 0.79% | 11.10% | 27.99% | 16.91% |
EPS (Basic) | 3.55 | 3.37 | 2.45 | 0.93 | 0.07 | -1.63 |
EPS (Diluted) | 3.54 | 3.36 | 2.45 | 0.93 | 0.07 | -1.63 |
EPS Growth | 37.02% | 37.33% | 163.52% | 1272.53% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 76.62 | 81.42 | 77.96 | 21.26 | 7.9 | -28.05 |
Free Cash Flow Per Share | 2.51 | 2.67 | 2.79 | 0.77 | 0.32 | -1.44 |
Dividend Per Share | 1.224 | 1.224 | 1.224 | 0.123 | - | - |
Dividend Growth | 0% | 0% | 891.50% | - | - | - |
Gross Margin | 77.37% | 77.87% | 78.50% | 75.04% | 75.83% | 70.30% |
Operating Margin | 31.70% | 32.63% | 27.35% | 13.37% | -6.25% | -68.39% |
Profit Margin | 32.50% | 33.47% | 30.67% | 16.11% | 1.59% | -56.34% |
Free Cash Flow Margin | 23.06% | 26.58% | 34.98% | 13.32% | 7.43% | -49.83% |
EBITDA | 114.99 | 108.95 | 68.84 | 28.72 | -0.06 | -30.15 |
EBITDA Margin | 34.62% | 35.57% | 30.89% | 17.99% | -0.06% | -53.56% |
D&A For EBITDA | 9.67 | 9 | 7.88 | 7.38 | 6.57 | 8.35 |
EBIT | 105.33 | 99.95 | 60.95 | 21.34 | -6.64 | -38.5 |
EBIT Margin | 31.70% | 32.63% | 27.35% | 13.37% | -6.25% | -68.39% |
Effective Tax Rate | 7.94% | 2.17% | 0.04% | 0.10% | 1.40% | - |